ADVANZ PHARMA Corp.
DelistedCIK 1642271fmd_0FTGPRYNYV605B13E61BGHBCHYManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2015 to Dec 31, 2017, 3 periods
| Line item | FY2015 | FY2016 | FY2017 |
|---|---|---|---|
| Total revenues | 394 | 816 | 626 |
| Cost of revenue | 94 | 221 | 191 |
| Gross profit | 300 | 595 | 436 |
| Research and development | 15 | 41 | 31 |
| Selling, general and administrative | 53 | 108 | 89 |
| Total operating expenses | 219 | 1,537 | 1,600 |
| Operating income | 80 | (942) | (1,165) |
| Income before taxes | (52) | (1,349) | (1,627) |
| Income tax expense | (23) | (35) | (37) |
| Net income from continuing operations | (29) | (1,314) | (1,591) |
| Net income | (32) | (1,316) | (1,591) |
| Net income to common shareholders | (29) | (1,314) | (1,591) |